



Background: People with dementia may not receive the same quality of palliative care as those 
with other life-limiting conditions, particularly at end of life (EOL).  
Aims: To understand the best way to examine pain for this population. 
Methods: A systematic review of tools to assess pain in patients with dementia near the end 
of life. We searched PubMed; (Ovid) Medline; (Ovid) Embase; (EBSCO Host) CINAHL Plus; 
(ISI) Web of Science; (Ovid) Psycinfo; (Ovid) PsycArticles; and Scopus.  
Findings: Fifteen articles were identified which were synthesised qualitatively.  
Conclusion: There are a range of pain assessment tools which are appropriate for use for this 
population but fifteen studies used a formal tool. To improve the quality of research for 
measurement and management of pain in this population, a more robust approach is needed.  
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Key points: 
• Most studies to assess pain measurement for people with dementia at end of life were 
done posthumously. 
• There is a lack of data on what happens to pain levels after pain has been assessed and 
mitigation applied. 
• There is an urgent need for well-validated pain assessment tools for this population. 
• A quasi-experimental research design may provide an ethical approach to examine 
pain assessment in patients with dementia. 
Pain tools in EoL care for dementia   1 
 
1. Introduction 
1.1 Pain assessment and treatment at end-of-life (EoL) in dementia 
Dementia is a progressive, neurodegenerative disease characterised by a worsening ability to 
think, remember and learn (Dyer et al. 2018). It is a terminal illness (Alzheimer’s Society 2014) 
and while some treatments can alleviate symptoms there is no cure. In the community it is not 
fully understood that dementia per se is life-limiting (O’Shea et al. 2015), with many people 
with dementia and their families unprepared for healthcare decision making at the end of life. 
This, combined with uncertainty surrounding the disease trajectory and difficulty in predicting 
prognosis at this end stage (O’Shea et al. 2015), makes effective symptom assessment crucial. 
 
Smith (2000) lists the components of a good death as knowing when it is coming, having 
dignity and privacy, pain and symptom control, choice and control about where it occurs, 
access to information and expertise, access to spiritual or emotional support, access to hospice 
care in any location, control over who is present, ability to issue advance directives, time to say 
goodbye and avoidance of futile life-sustaining treatment. Holdsworth (2015) summarises the 
general consensus of a good death as one which is pain and symptom free, in which the patient 
has dignity and independence, in which family are present and are supportive and in which 
there is an awareness in health care professionals that death is imminent which is accompanied 
by good communication. Palliative care allows for the provision of quality care, especially 
relief from suffering to those with terminal illnesses (Morrison and Meier 2004; Seow et al. 
2018). Typically suffering is seen as comprising physical pain, psychological distress and, in 
some cases, spiritual distress (Aminoff and Adunsky 2006). 
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Although there is evidence that patients with dementia at EoL may experience the same 
symptom burden as those with cancer and other terminal illnesses parity of palliative care is 
not always the case (Martinsson et al. 2018). A number of studies comparing groups of people 
with dementia against groups of people with cancer at EoL (Chen et al. 2017; Huang et al. 
2017; Martinsson et al. 2018) found that those with dementia as well as cancer were more likely 
to have stays in hospital which involve distressing transfers, more likely to be in Intensive Care 
(ICU), more likely to have invasive procedures and less likely to receive hospice care than 
those with cancer and without dementia. Martinnson et al. (2018) measured thirteen EoL quality 
care indicators and found that dementia patients were less likely to receive specific pain 
assessment.   
 
The “gold standard” of pain management defines pain as whatever the patient says it is and 
specifies that associated assessment be continuous (Pasero and McCaffery 1999).  It is often 
underdiagnosed and undertreated in patients with dementia at end of life (Abbey et al. 2004; 
Hanson et al. 2018), because they are both less able to communicate their needs (Aminoff and 
Adunsky 2006) and the assumption that all distress and problem behaviours result from the 
illness. Dening (2017) summarises outcomes of poor pain management as increased discomfort 
and distress, induced delirium and confusion and possible inappropriate prescribing of 
antipsychotic medications and sedatives. Caring for people with dementia is complex for both 
families (Aminoff 2005) and healthcare professionals. Behaviours induced by pain are often 
misinterpreted (Pryor and Clarke 2017) and not treated effectively resulting in distress and sub-
optimal palliative patient care (Aminoff and Adunsky 2006). 
 
Pain tools in EoL care for dementia   3 
 
1.2 Rationale and objectives 
Other systematic reviews have looked at EoL care for people with dementia. The efficacy of a 
palliative care approach in dementia was investigated by Sampson et al. (2005). This identified 
one Random Control Trial (RCT) which did not address pain specifically (Ahronheim et al. 
2000) and a second study which addressed discomfort rather than pain (Volicer et al. 1994). 
Other reviews have addressed the issue by including populations with dementia as comparator 
groups. A 2014 systematic review (Moens et al.) addressed the issue of EoL palliative care by 
comparing cancer with eight non-cancer related illnesses including dementia.  
 
This systematic review examines the tools used in research to measure pain at end of life in 
people with dementia and provides an overview of research quality as well as addressing 
problems, issues and gaps. The PICOTS framework was used to develop the correct search 
strategy and establish eligibility criteria (Table 1). 
  
Table 1 here 
2. Method 
2.1 Design 
This review was conducted and reported using the Preferred Reporting items for Systematic 
Reviews and Meta-Analysis: the PRISMA statement (Moher et al. 2010) and registered with the 
PROSPERO database (PROSPERO CRD42019130806). 
 
2.2 Search methods 
A systematic search of the following databases was conducted: PubMed; (Ovid) Medline; 
(Ovid) Embase; (EBSCO Host) CINAHL Plus; (ISI) Web of Science; (Ovid) Psycinfo; (Ovid) 
PsycArticles; and Scopus. A grey literature search used Google Scholar. A number of reviews 
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of Google Scholar concluded that while it is not suitable as a stand-alone systematic review 
resource it can be a powerful addition to database searches (Atkinson and Cipriani 2018; 
Haddaway et al. 2015). It is recommended to limit findings from Google Scholar to the first 
200 to 300 results (Atkinson and Cipriani 2018; Haddaway et al. 2015). This was adopted for 
the current review. The search strategy for the Medline database is documented in Appendix 
1. This search was adapted for use in the remaining databases searched. 
 
2.3 Study Selection 
Three reviewers were involved in study selection (GMcA, KN, GL) with initial searches 
completed by GMcA. Results were independently screened by title (GMcA and KN). Applied 
criteria included studies: available in English; published between 2000-2018 (ensuring 
examination of the most recent research); addressing dementia patients at end of life; and 
finally those concerned with pain assessment as part of palliative care. Searches were redone 
in February 2020 to identify more recent studies. Reviews, qualitative studies and case studies 
were excluded. Systematic reviews identified as part of the search were used for quality 
checking purposes and not included in the final narrative synthesis. There was no threshold 
population size as it was recognised that for ethical reasons this is a difficult area in which to 
conduct research. Following title screening, abstracts were extracted (GMcA) and 
independently reviewed (GMcA and KN). Agreement rate was calculated as a percentage of 
the number of scripts agreed divided by the total number reviewed. GL screened the abstracts 
and consensus was reached between all three reviewers before proceeding to data extraction. 
The data extraction form was agreed by all three reviewers and GMcA performed data 
extraction.  
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2.4 Data Analysis 
Included studies were rated for quality using the Quality Assessment Tool for Quantitative 
Studies (QATQS) (National Collaborating Centre for Methods and Tools, 2008; Thomas et al. 
2004). The tool uses six rated components using the definitions shown in Table 2. Studies with 
no weak and those with at least four strong ratings were judged to be strong. Studies with less 
than four strong ratings and one weak rating were considered moderate. Studies with two or 
more weak ratings are considered weak. Rating of the quality of included studies was 
conducted independently by GMcA and KN, with differences identified and resolved through 
discussion. Consensus was reached between all three reviewers before proceeding.  
 
Tools such as the Grading of Recommendations, Assessment, Development and Evaluation 
(GRADE) Working Group criteria (Atkins et al. 2004; Guyatt et al. 2008) define quality as the 
confidence in an estimate of effect drawn from a body of evidence. Because none of the studies 
using the same tool included a control group no effect sizes were derived. Fifteen studies used 
a tool to assess pain, with three applied in more than one study. However because of 
overlapping samples, differences in timing of measurement, or the manner in which results 
were reported it was not feasible to compare or grade them.  
 
Table 2 here 
3. Results 
Initial searches produced 3033 paper for further scrutiny. Following removal of duplicates 1550 
papers were examined, with a further 1244 removed after the paper titles were screened. 
Agreement between GMcA and KN at this stage was 84%. Consensus was reached by 
discussion before abstract screening was performed independently. After abstract screening a 
further 236 studies were removed.  Agreement between GMcA and KN at this stage was 80%, 
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with consensus reached after the inclusion of reviewer 3 (GL). Seventy full text articles were 
assessed for eligibility, with fifty-seven excluded and the remaining thirteen synthesised. Two 
studies were added when searches were rerun in 2020. Results are shown in Figure 1.  
 
Figure 1 here 
 
3.1 Study characteristics 
Two excluded studies were systematic reviews (Moens et al. 2014; Sampson et al. 2005) which 
were used as a quality check for inclusion of other studies. Three studies reported on the same 
retrospective data (medical charts of nursing home residents diagnosed with dementia but who 
died from cancer) (Monroe and Carter 2010; Monroe et al. 2012; Monroe et al. 2013) Two of 
these studies used the same set of data (fifty-five people diagnosed with dementia and cancer) 
and the third analysed a subset of forty-eight of these. All three studies remained in this review 
but the number of participants was reduced by 103 reflecting the overlap. Table 3 shows the 
summary details of the studies included.  
 
Table 3 – summary table here 
No RCTs were conducted in this sample of studies and only one study used a quasi-
experimental design (Verreault et al. 2018). The majority of studies were cross-sectional with 
eight out of the fifteen conducted retrospectively after death. A common method was to review 
medical charts after death.  
 
Three studies had pain assessment for those at EoL with dementia as a primary focus (Monroe 
and Carter 2010; Monroe et al. 2012; Romem et al. 2015) with the remainder including pain as 
part of a wider focus on symptom management. In line with the PICOTS framework, 
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characteristics of included studies are discussed in terms of participants, interventions, 
comparators, outcomes and setting.  
 
3.2 Participant characteristics 
Studies involved 6446 people with 1555 having dementia (of these sixty-six also had cancer). 
Of the remaining, 5657 were receiving EoL care but their condition was not specified, ninety-
one had cancer with no dementia and fifty-one had COPD. Most patients were female 
(highest percentage recorded 96%) (Klapwijk et al. 2014).  One study examining EoL 
patients on a long-term geriatric ward included a minority of females (39%) (Aminoff and 
Adunsky 2005). Two studies reported an equal distribution of males and females (Romem et 
al. 2015; Soares et al. 2018). The overwhelming majority of studies took place in developed 
countries: six in the USA (Albrecht et al. 2013; Monroe and Carter 2010; Monroe et al. 2012; 
Monroe et al. 2013; Romem et al. 2015; Volicer et al. 2003); two in Belgium (Hermans et al. 
2017; Vandervoort et al. 2013); and one each in Israel (Aminoff and Adunsky 2005), France 
(Nourhashemi et al. 2012), Netherlands (Klapwijk et al. 2014), England (Sampson et al. 
2018), Brazil (Soares et al. 2018), Canada (Verreault et al. 2018) and New Zealand (Boyd et 
al. 2019). 
 
3.3 Intervention characteristics 
One study applied an intervention – a quasi-experiment comparing the effectiveness of an 
intervention versus usual care (Verreault et al. 2018): this took place in a long-term care facility 
with 193 participants, of whom ninety-seven received a five-component intervention, including 
training in use of the Pain Assessment Checklist for Seniors with Limited Ability to 
Communicate scale (PACSLAC) to assess pain. The ninety-six people in the control group 
received usual care. The groups were located in different long-term care facilities, two facilities 
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implemented the intervention and two applied usual care. All residents included in the study 
were at either stage ‘e, f’ of the Functional Assessment Staging of Alzheimer’s Disease (FAST) 
or had profiles ‘13 or 14’ on the Functional Autonomy Measurement System iso-SMAF. 
Baseline comparisons were established by measuring Quality of Care (QOC) and Quality of 
Dying (QOD) over a six-month period before the study began. Only residents who died during 
the study period were included. The main focus of the study was not management of pain but 
rather the assessment of a multidimensional intervention, so pain was not reported as a stand-
alone measure. Pain measurements were done using the PACSLAC, described below. They 
were then rolled into reporting of symptoms using the Symptom Management at the EoL in 
Dementia scale (SM-EOLD), also described below.  
 
Table 4 here  
 
Although not delivered as interventions the fourteen other studies did employ tools to measure 
symptoms. Table 4 shows the formal tools used in the studies, including details of the tools and 
measurement outcomes. Nine studies used a formal tool that assessed a range of symptoms, 
including pain (Aminoff and Adunsky 2005; Boyd et al. 2019; Hermans et al. 2017; Monroe 
and Carter 2010; Monroe et al. 2012; Monroe et al. 2013; Soares et al. 2018; Vandervoort et 
al. 2013; Volicer et al. 2003). Six studies used a formal tool to assess and report pain 
specifically (Klapwijk et al. 2014; Nourhashemi et al. 2012; Romem et al. 2015; Sampson et 
al. 2018; Soares et al. 2018; Verreault et al. 2018).  
 
Six tools for measuring pain at the symptom-level were used: (1) the 9-item Symptom 
Management at the EoL in Dementia scale (SM-EOLD) (Boyd et al. 2019; Vandervoort et al. 
2013; Volicer et al. 2003) – while scores are usually summed it can report pain as standalone 
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(as in Vandervoort et al. 2013); (2) the 14-item Comfort Assessment in Dying at EoL in 
Dementia scale (CAD-EOLD), used in one study  (Boyd et al. 2019), examines physical and 
emotional distress, wellbeing and symptoms associated with dying, with one item addressing 
pain – again, while scores are normally summed pain can be standalone (as in Vandervoort et 
al. 2013); (3) the Mini Suffering State Examination Scale (MSSE) used by one study (Aminoff 
and Adunsky 2005) addresses ten elements of suffering (including pain) – while the study did 
not report pain as measured by the scale, it did report the proportion of the population reporting 
pain in the last week of life; (4) the 17-item Discomfort Behaviour Scale (DBS), used by three 
studies derived from the same sample (Monroe and Carter 2010; Monroe et al. 2012; Monroe 
et al. 2013) addresses behaviours indicating pain or discomfort with outcomes reported as 
means; (5) the Palliative care Outcome Scale (POS), used by one study (Hermans et al. 2017), 
is a 10-item multidimensional scale covering physical, psychological, emotional and spiritual 
aspects of a person’s life with the first eight (including a pain question) scored on a 5-point 
Likert scale ranging from no problem to overwhelming problem and findings reported as means 
– and pain scores reported separately; and finally (6) the Edmonton Symptom Assessment 
Scale (ESAS) used by one study (Soares et al. 2018) assesses nine symptoms, including pain 
(scored from 0-10) with a pain threshold for inclusion set from moderate to severe. This study 
reported pain as the proportion of people for whom pain was rated as moderate to severe.  
We note that in terms of the psychometric properties for the purpose of measuring pain it is not 
possible to assess these scales as studies using them utilise overall scale scores and pain is only 
one item on each scale. 
 
Four tools measured pain alone: (1) the Pain Assessment IN Advanced Dementia scale 
(PAINAD)-, used in three studies (Klapwijk et al. 2014; Romem et al. 2015; Sampson et al. 
2018), is a 5-item measure each scored 0 to 2, summing to 0-10 with 2 or more indicating pain; 
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(2) the Elderly Pain Caring Assessment scale (EPCA) used by one study (Nourhashemi et al. 
2012) is an 8-item measure based on behaviours with each item scored from 0-4 in increasing 
pain severity; (3) the PACSLAC (Verreault et al. 2018) comprises four subscales concerned 
with facial expression (13 items), social/personality/mood issues (12), activity/body movement 
(20) and physiological changes/eating sleeping changes/vocal behaviours (15 items) - here 
presence or absence of each item is noted over a period of time and scores are summed; and 
finally (4) one study (Albrecht et al, 2013) used the 5-item FLACC scale (Face, Legs, Activity, 
Cry, Consolability), each scored 0 to 2, with pain either recorded on a rating scale (0-10) or 
categorised as not present, mild discomfort, moderate pain, or severe discomfort/pain or both. 
 
With respect to their psychometric properties Goebel et al. (2019) found PAINAD to be a 
reliable and valid tool for pain screening in medical or surgical settings. However, a recent 
systematic review (Tapp et al. 2019) assessing pain assessment tools for non-verbal patients at 
EoL concluded that more work is needed to improve the scientific basis for testing and 
recommended a new tool be developed for this population. The EPCA assessment scale was 
assessed by Morello et al. (2007) was found to have good psychometric properties and was 
included in a 2016 systematic review (Husebo et al. 2016).  
 
One meta-review (Lictner et al. 2014) of systematic reviews of pain assessment in dementia 
concluded that no tool could be recommended for use in this area due to a lack of rigorous 
testing of psychometric properties. However, Montoro-Lorite and Canalias-Reverter (2018) 
reviewed pain management protocols for dementia and recommended PACSLAC as effective 
in residential settings. No recent information could be found on the psychometric properties of 
the FLACC which was originally developed for use in children and was adapted as the 
PAINAD scale for use in adults (Montoro-Lorite and Canalias-Reverter 2018). 
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3.4 Comparator characteristics 
Only one study used a formal comparator group (Verreault et al. 2018); patients at terminal 
stage of dementia compared with residents in long-term care. One group received the 
intervention (as described above) and the other received usual care. Other studies incorporate 
less formal comparators. Most studies used records of people who had already died. The most 
frequently studied comparisons were between people with and without dementia (Albrecht et 
al. 2013; Boyd et al. 2019); people with dementia and people with cancer (Boyd et al. 2019; 
Martinsson et al. 2018; Romem et al. 2015; Soares et al. 2018); different types of care settings 
(Sampson et al. 2018); and people who died from COPD (Romem et al. 2015). 
 
3.5 Outcome characteristics 
The diversity of tools meant that a meta-analysis was impossible for this current review. 
Additionally, we could not determine which tools were useful in detecting pain reduction. 
Studies which used the same tool sometimes reported the results in different ways adding to 
the barriers to quantitative analysis. For example, the PAINAD scale was used in three studies: 
Klapwijk et al. (2104) reported outcomes as mean scores; while both Romem et al. (2015) and 
Sampson et al. (2018) reported outcomes as a percentage of people who made pain reports.   
 
Six studies used four formal tools for the assessment of pain alone (Albrecht et al. 2013; 
Klapwijk et al. 2014; Nourhashemi et al. 2012; Romem et al. 2015; Sampson et al. 2018; 
Verreault et al. 2018). Outcomes were reported either as percentages of people who had pain, 
or as a mean of scores for the tool that was used. Albrecht et al. (2013) used the FLACC scale 
and reported that 19% of people reported pain (compared with 31% of a non-dementia 
comparison group). Klapwijk et al. (2014) used PAINAD and reported a mean pain score (1.9, 
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SD=1.7). Nourhashemi et al. (2012) used the EPCA (0-32) and reported a mean score of 8.58 
and a median score of 7.  Romem et al. (2015) used PAINAD and reported outcomes as a 
percentage of people who had pain (with 75% of dementia patients noted as having clinically 
significant pain). Sampson et al. (2018) used PAINAD and reported outcomes as percentage 
of people who had pain (here 11% of people had pain at rest and 61% had pain when they 
moved). Verreault et al. (2018) carried out the intervention study and measured pain using 
PACSLAC. However, this study did not report PACSLAC scores or percentages of people who 
had pain, but reported pain scores combined as part of the SM-EOLD score which reported 
symptoms at an overall level.  
 
Nine studies used formal tools for the assessment of a range of symptoms including pain. The 
DBS was used in three studies (Monroe and Carter 2010; Monroe et al. 2012; Monroe et al. 
2013) each of which involved people with dementia who had died from cancer. The 2012 and 
2013 studies reported mean DBS scores of 7 (range 3-48), while the 2010 study reported mean 
scores 3.54 (SD=5.49) and 10.81 (SD=14.42) for Caucasian and African American patients 
respectively.  
 
The SM-EOLD scale was used in three studies (Boyd et al. 2019; Vandervoort et al. 2013; 
Volicer et al. 2003). Volicer et al. (2003) did not report pain as a stand-alone result. 
Vandervoort et al. (2013) reported pain as mean scores taken in the last month and the last week 
of life - which for the last month of life was 1.9 on a range from 0 to 5 and for the last week 
was 2.0. Boyd et al. (2019) recorded reported pain during the last month of life, –with a mean 
of 0.6 and range 0-5. This study was also the only study to use the CAD-EOLD scale to measure 
pain in the last week of life. It was reported as a stand-alone measure. The mean score was 2.3 
with range 1 to 3.  
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The MSSE scale was used in one study (Aminoff and Adunsky, 2005). Pain scores were not 
reported. The POS-Staff version was used in one study (Hermans et al. 2017), with outcomes 
reported as mean and median scores - here the mean was 1 (range=0-4), with the median=0.5. 
The final study, which addressed pain as part of a wider assessment of symptoms, used the 
EDMS (Soares et al. 2018). Thirty-four percent of residents with dementia reported pain, 
compared with 57% of people who had cancer.  
  
3.6 Setting characteristics 
Six studies used data of residents or ex-residents in nursing homes (Hermans et al. 2017; 
Klapwijk et al. 2014; Monroe and Carter, 2010; Monroe et al. 2012; Monroe et al. 2013; 
Vandervoort et al. 2013). Additional care facility settings included an acute care facility (Soares 
et al. 2018), long-term care facilities (Boyd et al. 2019; Verreault et al. 2018) and a hospice 
(Albrecht et al. 2013), Volicer et al. (2003) and Sampson et al. (2018) compared experiences 
between home care and institutional care. Three studies had a hospital setting (Aminoff and 
Adunsky 2005; O’Shea et al. 2015; Romen et al. 2015).  
 
3.7 Limitations of the literature 
There are major limitations in the reviewed studies, including use of medical records to collect 
data or third parties such as relatives or medical staff. Given the nature of dementia it is difficult 
to recruit people into studies. Additionally, sample size calculations were not provided and 
appeared underpowered to detect differences.   
 
3.8 Strength of evidence 
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These limitations had implications for the quality of the evidence. No RCTs were available. 
No studies were rated as high quality, ten were assessed as weak and five assessed as of 
moderate quality (Boyd et al. 2019; Nourhashemi et al. 2012; Romem et al. 2015; Sampson et 
al. 2018; Verreault et al. 2018). Overall grading of evidence could not be performed due to the 
lack of the same or harmonised tools used in the studies. Only one tool specifically designed 
to measure pain alone was used in more than one study, PAINAD (Klapwijk et al. 2014; 
Romem et al. 2015; Sampson et al. 2018) and outcomes were not presented in the same way in 
all three studies.  
4.  Discussion 
This is the first systematic review to address issues of pain assessment in the dementia 
population specifically at end-of-life and how available tools are deployed. The primary 
purpose was to assess pain measurement in studies of end of life care for people with dementia.  
 
Pain and symptom control are crucial to a good death (Holdsworth 2015; Smith 2000; Morrison 
and Meier 2000) with physical pain being a central element of suffering (Aminoff and Adunsky 
2006). Although four tools that measure pain specifically were identified (PACSLAC, 
PAINAD, EPCA, and FLACC) and six identified which tools measure a full range of 
symptoms including pain (SM-EOLD, CAD-EOLD, MSSE, DBS, POS-Staff and ESAS) what 
is not known and what needs to be understood is the effectiveness of these tools in managing 
pain in the dementia population. There is a clear need to improve the quality of research that is 
conducted in pain measurement and management in dementia. Recommendations are set out 
in Table 5. 
  
Table 5 about here. 
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4.1 Conclusion 
Future research should include rigorous methodology which will permit evaluation of pain 
measurement and management for those with dementia at end of life. There are clear 
recruitment and ethical barriers to overcome in end of life research which increase when severe 
cognitive impairment is a major factor. To address methodological issues presented in the 
current body of research, study designs are required that allow the use of formal tools to be 
applied and assessed while addressing ethical considerations inherent in the topic domain. 
While RCTs may be problematic, Verreault et al. (2018) showed the possibility of 
implementing a quasi-experimental design which incorporated training and application of the 
comprehensive PACSLAC tool. Many people with dementia live in nursing or care homes at 
the end of life which provides opportunity for intervention studies to be conducted. Small 
sample sizes can be counteracted by introducing intervention designs across multiple care 
homes. The formal use of pain assessment tools can contribute to people at EoL having their 
pain needs met, and the interplay between research and practice can be used to increase 
momentum for improvement in both. 
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Table 1. The PICOTS framework as applied to the research question 
Category Criteria 
Population of interest People with a diagnosis of dementia who are at end-of-life 
Intervention of interest Tools used for the assessment and treatment of pain 
Comparator RCTs are not expected to be found for this population, however possible 
comparators are populations with another terminal illness at EoL 
 
Outcome of interest Pain measurement 
Timing Publication date 2000 or later 
Setting Any setting - home, nursing home, hospice, hospital 
  
  
Pain tools in EoL care for dementia   23 
 
Table 2. Quality assessment components and ratings. 
Component Strong Moderate Weak 
Selection bias Very likely to be representative 
of the target population and 
greater than 80% participation 
rate 
Somewhat likely to be 
representative of the target 
population and greater than 
60-79% participation rate 
 
All other responses or 
not stated 
Design RCT and CCT Cohort analytic, case-control, 
cohort or interrupted time 
series 
 
All other designs or 
design not stated 
Confounders Controlled for at least 80% of 
confounders 
Controlled for 60-79% of 
confounders 
Confounders not 
controlled for or not 
stated 
 
Blinding Blinding of outcome assessor 
and study participants to 
intervention status 
Blinding of either outcome 
assessor or study participants 
Outcome assessor and 
study participants are 
aware of intervention 





Tools are valid and reliable Tools are valid but reliability 
not described 





Follow-up rate of  80% or more 
of participants 
Follow-up rate of 60-79% of 
participants 
Follow-up rate of <60% 
of participants or 
withdrawals and 




Table 3. Summary of studies 
Author, year Country Design Sample and setting Main focus of study 
Volicer et al., 
2003 
US Retrospective survey 
(after death) 
Family caregivers of 154 people who died from 
dementia. Both home care and institutional care. 
Care receivers: 55% female, mean age 81.2 ± 7.5   
To promote establishment of evidence for making 
policy recommendations. To describe characteristics 
of enf-of-life (EoL) care in different settings.  To 
develop three scales designed specifically to measure 
end-of-life care outcomes in dementia 
Aminoff et al., 
2005 
Israel Prospective cohort End stage dementia patients (n=71) admitted to a 
long-term geriatric ward of a tertiary medical centre. 
39.4% female. Mean age 82.9 ± 8 
To evaluate the level of suffering in dementia patients 
during their final hospital stay 
Monroe et al., 
2010 
US Retrospective chart 
review (after death) 
Nursing home resident (n=55) who died from cancer 
with a diagnosis of dementia also. 54.5% female. 
Mean age 86.4 ± 7.84 
To explore the differences between African American 
and Caucasian nursing home residents pain 
management at EoL 
Nourhashemi et 
al., 2012 
France Prospective cohort Alzheimer’s patients (n=112) in the severe stage of 
the illness in hospital. 76.8% female. Mean age 
84.03 ± 6.96 
To describe the design of the ALFINE study and the 
characteristics of the recruited cohort 
Monroe et al., 
2012 
US Retrospective chart 
review (after death) 
Nursing home residents (n=48) with mild to severe 
dementia. 54% female. Mean age 86 ± 8 
To assess advanced cancer pain in older adults with 
dementia at EoL 
Albrecht et al., 
2013 
US Cross-sectional survey Hospice patients with dementia (n=450) and without 
dementia (n=4261). 55% female. Mean age 78±0.3. 
Patients with dementia: 61% female, mean age 85 ± 
0.7 
To quantify differences in quality measures between 
individuals in hospice with and without dementia 
Monroe et al., 
2013 
US Retrospective chart 
review (after death) 
Nursing home residents (n=55) with dementia who 
died from cancer. 54.5% female. Mean age 86.4±7.8 
To examine the associations between hospice 
enrolment, dementia severity and pain among nursing 
home residents who died from advanced cancer 
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sectional (after death) 
Nursing home residents who died from dementia 
(n=198). 61.5% female. Mean age 86.7 
To study how many deceased nursing home residents 
had dementia in Flanders, Belgium, to describe their 
clinical characteristics and quality of dying 
Klapwijk et al., 
2014 
Holland Prospective and 
retrospective cohort 
Nursing home residents with dementia at the EoL 
(n=24). 96% female. Mean age 91 
To describe the incidence and course of observed 
symptoms and treatment in people with dementia in 
the last days before their expected death 
Romem et al., 
2015 
US Retrospective chart 
review (after death) 
Patients with a terminal illness admitted to hospital, 
COPD (n=51, 64.7% female, mean age 75.8 ± 10.7), 
cancer (n=47, 44.7% female, mean age 73.7 ± 13.4), 
dementia (n=48, 50% female, mean age 85.9 ± 7.1) 
To explore if patients with dementia and COPD 
achieve less optimal pain control than patients with 
end-stage cancer 
Hermans et al., 
2017 
Belgium Cross-sectional  Nursing home residents anticipated to be in the last 
year of life (n=109, 68% female, mean age 87 
years). 55% were diagnosed with dementia. 
Descriptive s were not reported by diagnoses 
 To describe palliative care needs and symptoms of 
older adults anticipated to be in the last year life in 
Flemish nursing homes and evaluate whether these 
palliative care needs differ between residents with and 
without dementia 
Sampson et al., 
2018 
England Prospective cohort People with advanced dementia living at home and 
in nursing homes (n= 85). The majority were women 
(% not reported), mean age 85 years 
To describe the course of physical and psychological 
symptoms in those with advanced dementia. To 
examine health and social care service utilisation. To 
describe the care received at EoL 
Soares et al., 
2018 
Brazil Retrospective chart 
review (after death) 
People in a post-acute care facility (n=108) who had 
died from dementia (n=57, 49% female, mean age = 
86) or from cancer (n=54, 64% female, mean age = 
73)  
To estimate the prevalence and intensity of dyspnoea, 
pain and agitation among people dying with late stage 
dementia compared with those dying with advanced 
cancer 
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Author, year Country Design Sample and setting Main focus of study 
Verreault et al., 
2018 
Canada Quasi-experimental People living in a long-term care facility (193). 
Ninety-seven received a 5-component intervention 
including pain monitoring (76.3% female, mean age 
= 88.9 ± 9.4). 96 received usual care (69.7% female, 
mean age = 88.1 ± 6.2) 
To assess a multidimensional and multidisciplinary 
intervention to improve EoL care in advanced 
dementia in long-term care facilities 
Boyd et al., 2019 New Zealand Retrospective chart 
review (after death) 
Residents in 61 long-term care facilities (n=286) 
who had died from cancer (17%), dementia (49%), 
both cancer and dementia (4%) and other chronic 
illness (30%). For those who died from dementia 
60% were female. Mean age was not reported. For 
those with dementia 16% were 80 years old or 
younger, 54% were aged between 81-91 years and 
30% were 92 years old and above 
 
To compare symptoms before death of those in long-




Table 4. Details of pain tools and measurements 
Author, year Pain Assessment Tool  Duration of measurement Pain Assessed By Pain Score - people with dementia Study Quality 
Volicer et al., 
2003 
No tool that assessed pain 
independently. SM-EOLD is a 
symptom management scale which 
has 1 measure out of 9 addressing 
pain, with the scores summed. 
Not detailed Not detailed Not detailed Weak 
Aminoff et al., 
2005 
No tool that assessed pain 
independently. Mini Suffering State 
Examination Scale (MSSE) 
assesses 10 elements of suffering, 1 
of which is pain with scores 
summed. 
Weekly from admission till 
death 
Unclear if researchers, 
medical staff or carers did the 
ratings. 
MSSE scores overall were reported, 
pain alone was not however the study 
did report that in the last week, 18.3% 
of reported pain 
Weak 
Monroe et al., 
2010 
Discomfort Behaviour Scale Assessed after death Reports of pain in medical 
records 
Mean DBS score 
Caucasian patients: 3.54(SD=5.49) 





Elderly Pain Caring Assessment 
Scale 
Not detailed Caregiving staff Mean score = 8.58 
Median score = 7 
Moderate 
Monroe et al., 
2012 
Discomfort Behaviour Scale Assessed after death Reports of pain in medical 
records 
Mean DBS score = 7 (3-48) Weak 
Albrecht et al., 
2013 
FLACC scale (Face, Legs, Activity, 
Cry, Consolability) 
Once at last assessment Caregiving staff Pain reports 
19% of those with dementia  
31% of those without dementia  
Weak 
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Author, year Pain Assessment Tool  Duration of measurement Pain Assessed By Pain Score - people with dementia Study Quality 
Monroe et al., 
2013 
Discomfort Behaviour Scale Assessed after death Reports of pain in medical 
records 
Mean DBS score = 7 (3-48) Weak 
Vandervoort et 
al., 2013 
No tool that assessed pain 
independently. SM-EOLD is a 
symptom management scale which 
has 1 measure out of 9 addressing 
pain, with the scores summed 
Last month of life, last week 
of life 
Nursing staff Pain was extracted and reported alone  
Mean score = 1.9 (0-5) in last month of 
life  
mean score = 2(0-5) in last week of life 
Weak 
Klapwijk et al., 
2014 
Pain Assessment in Advanced 
Dementia scale 
Last week of life Care physicians Mean score = 1.9 (SD 1.7) Weak 
Romem et al., 
2015 
Pain Assessment in Advanced 
Dementia scale 
48 hours after admission to 
hospice 
Hospice staff 75% of dementia patients had pain 
reports of clinically significant pain  
Moderate 
Hermans et al., 
2017 
Palliative Care Outcome scale - 
staff version. 1 question addresses 
pain 
Once Caregivers mean score = 1.1 (0-4) 
median score = 0.5 (0-4) 
Weak 
Sampson et al., 
2018 
Pain Assessment in Advanced 
Dementia scale 
Every 4 weeks till 9 months or 
death 
Research staff  11% of patients reported pain at rest 
61% reported pain on movement 
Moderate 
Soares et al., 
2018 
Edmonton Symptom Assessment 
System which includes pain as one 
measurement. Numeric rating from 
0 (none) to 10 (worst). 
Pain intensity measured as 
percentage of patients with 
symptoms rated as moderate to 
severe 
Last 3 days of life Registered nurses. Pain reports rated moderate to severe 
34% of dementia patients  
57% of patients with cancer  
Weak 
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Author, year Pain Assessment Tool  Duration of measurement Pain Assessed By Pain Score - people with dementia Study Quality 
Verreault et al., 
2018 
Pain Assessment Checklist for 
Seniors with Limited Ability to 
Communicate (PACSLAC). 
Twice a day until 1 year or 
death. 
Nursing staff Pain not reported alone, rolled into SM-
EOLD score 
Moderate 
Boyd et al., 
2019 
SM-EOLD – last month of life 
 
CAD-EOLD – last week of life  
Last month of life 
Last week of life 
Registered nurses through 
survey after death 
Last month of death: people with 
dementia, SM-EOLD mean score in 
range 0-5 =0.6 
Last week of death: people with 
dementia, CAD-EOLD mean score in 






Table 5.  Recommendations 
Recommendation Detail 
Guidelines or protocols for the study of pain assessment at  
end of life for people with dementia 
While it is recognised that ethical considerations prohibit the use of RCTs in this group, this 
systematic review has shown that the use of a quasi-experimental design is possible in an ethical way 
and allows comparison of interventions versus usual care. 
 
Retrospective studies The majority of studies used to assess pain measurement have been retrospective, after the death of 
the patient. Implementing a prospective study design would ensure a more robust approach. 
 
A pain assessment tool The ideal outcome is to identify and standardise a tool which is effective and robust in the assessment 
of pain in this group in a research setting. In order to study outcomes in a meaningful way, tools 
should report pain measurement in a manner which allows comparison. This would facilitate 
measurement and meta-analysis. 
 
Use of a comparison group Studying the application of pain assessment tools is in itself valuable in this group. However in order 
to ensure that this assessment is of the same level as a group with established good quality EoL care, 
a comparison with people with cancer is recommended. 
 
Measurement of pain after assessment and intervention There is a lack of data on what happens to pain levels after pain has been assessed and mitigation 
applied. Study design should ensure that pain in re-assessed after pain medication has been 
administered. Therefore studies can report if the pain medication has reduced the pain and provided 
comfort.  
 
Measurement of health inequalities There is a dearth of research which addresses health inequalities in this group. Is pain assessment at 
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Appendix 1 
Medline Search Strategy Hits Retrieved  
11th December 2018 
1.exp dementia/ 
2.dementia*.mp. 
3. "frontotemporal dementia*".mp. 
4. "vascular dementia*".mp. 
5. alzheimer*.mp.  
6."lewy bod*".mp. 
 
7. 1 or 2 or 3 or 4 or 5 or 6 
 
8. exp terminal care/ 
9. "end-of-life car*".mp.  
10. "EOL car*".mp. 
11.exp palliative therapy/ 
12. "palliat*".mp. 
13. "palliat* car*".mp. 
14."palliat* medic*".mp. 
15. "palliat* treat*".mp. 
16."palliat* medic*".mp.  
17."terminal car*".mp.  
18."end-of-life treat*".mp.  
19."EOL treat*".mp.  
 
20. 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 
 




23. "analgesi* test*".mp. 
24. "pain management*".mp. 
25. pain.mp. 
26. "physical suffering*".mp. 
27. "pain measurement*".mp. 
28. "pain assessment*".mp.  
29. "pain treatment*".mp. 
30.  exp Analgesics/ 
 
31. 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 
 
32. 7 and 20 and 31 
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